Self-Experimenters: Malaria Vaccine Maven Baits Irradiated Mosquitoes with His Own Arm
Stephen Hoffman has given years of sweat—and lots of blood—on his quest to stop a global killer. Read the full article in Scientific American.|
Sanaria featured in The New York Times, The Soul of a New Vaccine
The sign on the wall reads “Emergency Response Procedures for a Mosquito Release.”
Among them are “Do Not Leave the Room or Open Any Doors!!!” and “Do Not Panic!”
Everything in the room is white, including the lab coats and surgical masks — for sterility, yes, but also the better to see a mosquito. Hanging next to the sign, in vivid Coast Guard orange, is the last line of defense, a brace of fly swatters.
This room, the mosquito dissection lab, in an unassuming biotech park in the Washington suburbs, is at the heart of one of the most controversial |
Sanaria CEO, Dr. Stephen L. Hoffman, interviewed on Al Jazeera English’s: The Pulse
Despite millions of dollars being spent on research there is no vaccine available against one of the world's biggest killer diseases -- Malaria. The Pulse looks at the parasite that has proved too complex for scientists and visits a clinical trial in Tanzania, which is showing unusual promise.
Whole parasite malaria vaccine to be manufactured for clinical trials
Sanaria Inc. and the PATH Malaria Vaccine Initiative has officially opened a one-of-a- kind clinical manufacturing facility to produce a vaccine that uses a weakened form of the malaria parasite to fight a disease that annually kills more than one million people, most of them African children.
Researchers aim to use mosquitoes to bite back at malaria
A US scientist is leading an international team of researchers using an army of blood- sucking mosquitoes to produce a potentially potent vaccine against malaria.
Malaria vaccine plant takes a gamble
In a nondescript office park tucked between a hospital and a strip mall thrive hundreds of thousands of the most infectious malaria-carrying mosquitoes ever born. They will be dissected for the motherlode that they carry -- baby malaria parasites, fodder for a new malaria vaccine.
New front launched in war on malaria
With $29.3M from the Gates Foundation, Rockville company opens plant today.
Fred Binka, Sanaria Advisory Board Member, featured in Newsweek
Read the full Newsweek article: “Giving Globally: The Search for Solutions“|
Sanaria featured in National Geographic magazine
Read the full story: Bedlam in the Blood, Malaria (Membership required). NatGeo Article|
Sanaria featured in ‘Kill or Cure’ documentary
Kill or Cure? The Malaria Vaccine takes viewers into the starkly different worlds of two cutting-edge investigators who may be moving us tantalizingly close to an achievement unheard of in the history of immunizations - an effective vaccine against a parasitic disease.
Bush recognizes social entrepreneurship
Like many such events, the recent White House Summit on malaria, which featured a speech and new grant announcements by Melinda Gates, was carefully choreographed with few surprises. But there was one.
President Bush began the closing keynote address by saying, “I want to thank those members of my Cabinet who are here, the ambassadors, the members of Congress, and I want to thank the social entrepreneurs who are with us today.” Bush then cited the Bill & Melinda Gates Foundation as “a fantastic example of social entrepreneurship, using business acumen to address social problems.”
Read more in the original |
$29.3M Gates grant boosts Sanaria
With the grant by the Bill and Melinda Gates Foundation announced Thursday, plus a new partnership with the Malaria Vaccine Initiative, Sanaria has reached $45 million in funding for developing a malaria vaccine.
Mosquito ‘factories’ to fight malaria
It's going to be fiddly work, but the saliva glands of mosquitoes are to be used as mini factories for churning out a novel vaccine against malaria. The vaccine is based on the whole parasite, rather than individual proteins, and may therefore work better than other vaccines in development because the body can mount a multi-pronged attack against it.
A conversation with Stephen Hoffman
Scientist survives several near misses — including a crash-landing — before turning his efforts toward fighting malaria
Off on his own in South America, he gets typhoid. In California, he is infected with malaria. On his way to a research site in Africa, the plane carrying him crash-lands.
Is Stephen Hoffman, the leader of malaria-vaccine developer Sanaria, scared by his past skirmishes with death? Sometimes.
Read the full story in the latest Washington Business Journal.|
Rockville’s Sanaria to test malaria vaccine
While Sanaria Inc. works to keep its focus on developing revenue streams, the estimated 3,000 children who die each day in a global resurgence of malaria add a humanitarian perspective for the Rockville company. This week, Sanaria, headed by CEO Stephen Hoffman, begins manufacturing its first run of a unique and promising malaria vaccine.
The Malaria Fighter
Sanaria's Dr. Hoffman is featured in Business 2.0 magazine's The Smart List edition.
An Interview with Dr. Stephen Hoffman
In Essential Science Indicators, Dr. Hoffman’s work can be found in the fields of Immunology and Microbiology. Dr. Hoffman is the founder, CEO, and Chief Scientific Officer of Sanaria, Inc. in Rockville, Maryland. In the interview below, he talks with Special Topics correspondent Gary Taubes about his highly cited work in malaria research.
Sanaria gets $4M in gov’t funds for malaria vaccine
Sanaria has snagged a research grant worth more than $4 million from the Army to work on a malaria vaccine, which the biotech company hopes to have in human testing a year from now.
Mosquito production mooted as fast track to malaria vaccine
In the October 2 issue of Nature, the News features a story about Sanaria's "audacious approach" to developing novel malaria vaccines.
